‘IF THEY HINDER TO SPEAK, HOW THEY LEARN IT?’ CAUSE AND SOLUTION FOR STUDENT RELUCTANT TO SPEAK IN SPEAKING CLASS
نویسندگان
چکیده
منابع مشابه
Autistics speak but are they heard ?
In this article, we argue that the exclusion of autistic people from meaningful involvement in research is both ethically and epistemologically problematic, and constitutes a significant barrier to research impact. By the term ‘meaningful’, we refer to the inclusion of different autistic voices not merely as sources of empirical material, but as active participants in the production of knowledg...
متن کاملHow to Speak a Language without Knowing It
We develop a system that lets people overcome language barriers by letting them speak a language they do not know. Our system accepts text entered by a user, translates the text, then converts the translation into a phonetic spelling in the user’s own orthography. We trained the system on phonetic spellings in travel phrasebooks.
متن کاملInterrelationships of Willingness to Speak and Cultural Identity with English L2 Speaking Proficiency
Regarding the belief that willingness to communicate is strongly tied with developing some insights into the L2 culture, such a connection may not be always positive and the issue of cultural attachment and identity may sometimes function as a hindrance. Individuals are believed to be highly emotional in terms of “religion and spirituality", among other components of cultural identity. This stu...
متن کاملSilent polymorphisms speak: how they affect pharmacogenomics and the treatment of cancer.
Polymorphisms in the human genome contribute to wide variations in how individuals respond to medications, either by changing the pharmacokinetics of drugs or by altering the cellular response to therapeutic agents. The goal of the emerging discipline of pharmacogenomics is to personalize therapy based on an individual's genotype. Due to the relatively large frequency of single-nucleotide polym...
متن کاملTranslating Pembrolizumab to Clinical Practice: Speak Immunology and Learn Fast!
T-cell checkpoint inhibitors treat the cancer patient's immune system potentially inducing significant long-term survival. Pembrolizumab demonstrates clinical activity in patients diagnosed with melanoma and other cancers. Its mode of action suggests a rationale for combination with other treatment modalities, urging oncologists to brush up their knowledge of immunology.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: SALEE: Study of Applied Linguistics and English Education
سال: 2020
ISSN: 2716-1617,2715-9795
DOI: 10.35961/salee.v1i02.80